Macrolide Drugs Market Size, Share, Trends, Growth and Forecast 2032
Macrolide Drugs Market by Drug Type (14-membered ring agents, 14-membered ring agents, 15-membered ring agents (Azalides), 16-membered ring agents, and Ketolides), By Distribution Channels (Hospital pharmacies, Clinics, Hospitals, Retail pharmacies, and Online pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.60 Billion | USD 6.69 Billion | 2.00% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Macrolide Drugs market, 2015 - 2024 (USD Billion)
- 2.2. Global Macrolide Drugs market : Snapshot
- Chapter 3. Macrolide Drugs market- Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Macrolide Drugs market drivers: Impact analysis
- 3.2.2. Increasing incidences of cancer
- 3.2.3. Increasing geriatric population
- 3.3. Market Restraints
- 3.3.1. Global Macrolide Drugs market restraints: Impact analysis
- 3.3.2. Lack of infrastructure
- 3.4. Opportunities
- 3.4.1. Technological advancements in Macrolide Drugs market Types
- 3.5. Porter's five forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. Threat from new entrants
- 3.5.4. Threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Type segment
- 3.6.2. Market attractiveness analysis, by sales channel segment
- 3.6.3. Market attractiveness analysis, by regional segment
- Chapter 4. Global Macrolide Drugs market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Macrolide Drugs market: company market share, 2015
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Type Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development, Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Macrolide Drugs market - Type Segment Analysis
- 5.1. Global Macrolide Drugs market: Type overview
- 5.1.1. Global Macrolide Drugs market revenue share, by Type, 2015 and 2024
- 5.2. 14-membered ring agents
- 5.2.1. Global 14-membered ring agents market, 2015 - 2024(USD Billion)
- 5.3. 15-membered ring agents (Azalides)
- 5.3.1. Global 15-membered ring agents (Azalides) market, 2015 - 2024(USD Billion)
- 5.4. 16-membered ring agents
- 5.4.1. Global 16-membered ring agents market, 2015 - 2024(USD Billion)
- 5.5. Ketolides
- 5.5.1. Global Ketolides market, 2015 - 2024(USD Billion)
- 5.1. Global Macrolide Drugs market: Type overview
- Chapter 6. Global Macrolide Drugs market -Sales Channel Segment Analysis
- 6.1. Global Macrolide Drugs market: Sales Channel overview
- 6.1.1. Global Macrolide Drugs market revenue share, by sales channel, 2015 and 2022
- 6.2. Hospital pharmacies
- 6.2.1. Global Hospital pharmacies market, 2015 - 2024(USD Billion)
- 6.3. Clinics
- 6.3.1. Global Clinics market, 2015 - 2024(USD Billion)
- 6.4. Hospitals
- 6.4.1. Global Hospitals market, 2015 - 2024(USD Billion)
- 6.5. Retail pharmacies
- 6.5.1. Global Retail pharmacies market, 2015 - 2024(USD Billion)
- 6.6. Online pharmacies
- 6.6.1. Global Online pharmacies market, 2015 - 2024(USD Billion)
- 6.1. Global Macrolide Drugs market: Sales Channel overview
- Chapter 7. Global Macrolide Drugs market - Regional Segment Analysis
- 7.1. Global Macrolide Drugs market: Regional overview
- 7.1.1. Global Macrolide Drugs market revenue share, by region, 2015 and 2021
- 7.2. North America
- 7.2.1. North America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.2.2. North America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.2.3. U.S.
- 7.2.3.1. U.S. Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.2.3.2. U.S. Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.2.4. Canada
- 7.2.4.1. Canada Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.2.4.2. Canada Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.2.5.2. Rest of North America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3. Europe
- 7.3.1. Europe Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.2. Europe Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.3. Germany
- 7.3.3.1. Germany Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.3.2. Germany Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.4. U.K.
- 7.3.4.1. U.K. Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.4.2. U.K. Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.5. France
- 7.3.5.1. France Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.5.2. France Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.6. Italy
- 7.3.6.1. Italy Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.6.2. Italy Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.7. Spain
- 7.3.7.1. Spain Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.7.2. Spain Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.8. Russia
- 7.3.8.1. Russia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.8.2. Russia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.3.9. Rest of Europe
- 7.3.9.1. Rest of Europe Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.3.9.2. Rest of Europe Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.4.2. Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.4.3. China
- 7.4.3.1. China Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.4.3.2. China Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.4.4. Japan
- 7.4.4.1. Japan Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.4.4.2. Japan Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.4.5. India
- 7.4.5.1. India Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.4.5.2. India Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.4.6. Australia
- 7.4.6.1. Australia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.4.6.2. Australia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.5.2. Latin America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.5.3. Mexico
- 7.5.3.1. Mexico Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.5.3.2. Mexico Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.5.4.2. Brazil Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.5.5. Argentina
- 7.5.5.1. Argentina Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.5.5.2. Argentina Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.5.6. Rest of Latin America
- 7.5.6.1. Rest of Latin America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.5.6.2. Rest of Latin America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 - 2024(USD Billion)
- 7.6.2. Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Saudi Arabia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.6.3.2. Saudi Arabia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6.4. UAE
- 7.6.4.1. UAE Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.6.4.2. UAE Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6.5. Qatar
- 7.6.5.1. Qatar Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.6.5.2. Qatar Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6.6. South Africa
- 7.6.6.1. South Africa Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.6.6.2. South Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.6.7. Rest of Middle East & Africa
- 7.6.7.1. Middle East & Africa Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
- 7.6.7.2. Middle East & Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
- 7.1. Global Macrolide Drugs market: Regional overview
- Chapter 8. Company Profile
- 8.1. Abbott Laboratories
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Therapy portfolio
- 8.1.4. Business strategy
- 8.1.5. Recent developments
- 8.2. Akorn, Inc.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Therapy portfolio
- 8.2.4. Business strategy
- 8.2.5. Recent developments
- 8.3. Eli Lilly & Co.
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Therapy portfolio
- 8.3.4. Business strategy
- 8.3.5. Recent developments
- 8.4. Fresenius Kabi USA
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Therapy portfolio
- 8.4.4. Business strategy
- 8.4.5. Recent developments
- 8.5. Gland Pharma Limited
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Therapy portfolio
- 8.5.4. Business strategy
- 8.5.5. Recent developments
- 8.6. Macrolide Pharmaceuticals
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Therapy portfolio
- 8.6.4. Business strategy
- 8.6.5. Recent developments
- 8.7. Neo Química
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Therapy portfolio
- 8.7.4. Business strategy
- 8.7.5. Recent developments
- 8.8. Mylan N.V.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Therapy portfolio
- 8.8.4. Business strategy
- 8.8.5. Recent developments
- 8.9. Pfizer, Inc.
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Therapy portfolio
- 8.9.4. Business strategy
- 8.9.5. Recent developments
- 8.10. Merck & Co.
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Therapy portfolio
- 8.10.4. Business strategy
- 8.10.5. Recent developments
- 8.11. Merck & Co.
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Therapy portfolio
- 8.11.4. Business strategy
- 8.11.5. Recent developments
- 8.12. Sandoz International GmbH
- 8.12.1. Overview
- 8.12.2. Financials
- 8.12.3. Therapy portfolio
- 8.12.4. Business strategy
- 8.12.5. Recent developments
- 8.13. Teva Pharmaceutical Industries Ltd.
- 8.13.1. Overview
- 8.13.2. Financials
- 8.13.3. Therapy portfolio
- 8.13.4. Business strategy
- 8.13.5. Recent developments
- 8.14. WOCKHARDT
- 8.14.1. Overview
- 8.14.2. Financials
- 8.14.3. Therapy portfolio
- 8.14.4. Business strategy
- 8.14.5. Recent developments
- 8.1. Abbott Laboratories
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Macrolide Drugs market revenue, 2015 – 2024 (USD Billion)
4. Porter’s five forces analysis
5. Macrolide Drugs market attractiveness analysis, by type segment
6. Macrolide Drugs market: Market attractiveness analysis, by sales channel segment
7. Macrolide Drugs market: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015
9. Global Macrolide Drugs market revenue share by Type, 2015 and 2024
10. Global 14-membered ring agents market, 2015 – 2024 (USD Billion)
11. Global 15-membered ring agents (Azalides) market, 2015 – 2024 (USD Billion)
12. Global 16-membered ring agents market, 2015 – 2024 (USD Billion)
13. Global Ketolides market, 2015 – 2024 (USD Billion)
14. Global Macrolide Drugs market revenue share by sales channel, 2015 and 2024
15. Global Macrolide Drugs market for Hospital pharmacies, 2015 – 2024, (USD Billion)
16. Global Macrolide Drugs market for Clinics, 2015 – 2024, (USD Billion)
17. Global Macrolide Drugs market for Hospitals, 2015 – 2024, (USD Billion)
18. Global Macrolide Drugs market for Retail pharmacies, 2015 – 2024, (USD Billion)
Table Of Tables
List of Tables
1. Macrolide Drugs market: Market Snapshot
2. Drivers of global Macrolide Drugs market: Impact analysis
3. Restraints of global Macrolide Drugs market: Impact analysis
4. North America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
5. North America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
6. U.S. Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
7. U.S. Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
8. Canada Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
9. Canada Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
10. Rest of North America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
11. Rest of North America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
12. Europe Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
13. Europe Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
14. Germany Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
15. Germany Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
16. France Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
17. France Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
18. U.K. Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
19. U.K. Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
20. Italy Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
21. Italy Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
22. Spain Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
23. Spain Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
24. Russia Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
25. Russia Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
26. Rest of Europe Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
27. Rest of Europe Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
28. Asia Pacific Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
29. Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
30. China Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
31. China Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
32. Japan Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
33. Japan Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
34. India Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
35. India Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
36. Australia Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
37. Australia Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion) India Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
38. Rest of Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
39. Rest of Asia Pacific America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
40. Latin America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
41. Mexico Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
42. Mexico Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
43. Brazil Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
44. Brazil Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
45. Argentina Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
46. Argentina Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
47. Rest of Latin America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
48. Rest of Latin America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
49. Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
50. Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
51. Saudi Arabia Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
52. Saudi Arabia Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
53. UAE Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
54. UAE Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
55. Qatar Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
56. Qatar Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
57. South Africa Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
58. South Africa Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
59. Rest of Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion)
60. Rest of Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
Methodology
FrequentlyAsked Questions
Macrolide drugs are a class of antibiotics used to treat bacterial infections. They work by inhibiting bacterial protein synthesis
The global Macrolide Drugs market is expected to be driven by the rising bacterial infections and demand for broad-spectrum antibiotics. Continued use in respiratory and sexually transmitted infections supports growth.
According to study, the global Macrolide Drugs market size was worth around USD 5.60 Billion in 2023 and is predicted to grow to around USD 6.69 Billion By 2032.
The global Macrolide Drugs market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 2.00% during the forecast period from 2024-2032.
The global Macrolide Drugs industry is projected to be challenged by Challenges include antibiotic resistance, regulatory scrutiny, and pricing pressure from generics.
The Opportunities include demand for respiratory and bacterial infection treatments, emerging market healthcare expansion, and development of improved formulations will offer significant growth opportunities in the Macrolide Drugs market.
Next-generation macrolides with improved resistance profiles; targeted delivery formulations; expanded use in respiratory and infectious diseases are the emerging trends and innovations impacting the Macrolide Drugs market.
The global Macrolide Drugs market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Macrolide Drugs market are; Abbott Laboratories, Akorn, Inc., Eli Lilly & Co., Fresenius Kabi USA, Gland Pharma Limited, Neo Química, Macrolide Pharmaceuticals, Mylan N.V., Pfizer, Inc., Sanofi, Merck & Co., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and WOCKHARDT. and others.
The report explores crucial aspects of the Macrolide Drugs market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
